Feeney John Joseph 5
5 · Vanda Pharmaceuticals Inc. · Filed Feb 13, 2012
Insider Transaction Report
Form 5
Feeney John Joseph
Acting Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2011-02-18+7,500→ 7,500 total - Sale
Common Stock
2011-02-18$7.25/sh−2,985$21,641→ 4,515 total - Exercise/Conversion
Restricted Stock Unit
2011-02-18−7,500→ 22,500 total→ Common Stock (7,500 underlying)
Footnotes (3)
- [F1]Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
- [F2]The Restricted Stock Units vest in four equal annual installments beginning January 1, 2011. Vested shares will be delivered on the First Permissable Trading Day (as defined in the Restricted Stock Unit Agreement) that occurs on or after the day when the Restricted Stock Units vest.
- [F3]N/A